c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

作者: Celina M. D'Cruz , Edward J. Gunther , Robert B. Boxer , Jennifer L. Hartman , Louis Sintasath

DOI: 10.1038/84691

关键词:

摘要: Although the process of mammary tumorigenesis requires multiple genetic events, it is unclear to what extent carcinogenesis proceeds through preferred secondary pathways following a specific initiating oncogenic event. Similarly, which established tumors remain dependent on individual mutations for maintenance transformed state unknown. Here we use tetracycline regulatory system conditionally express human c-MYC oncogene in epithelium transgenic mice. MYC encodes transcription factor implicated cancers. In particular, amplification and overexpression breast cancers associated with poor prognosis, although mechanisms by promotes tumor progression are poorly understood. We show that deregulated expression this inducible results formation invasive adenocarcinomas, many fully regress deinduction. Approximately half these harbor spontaneous activating point ras family proto-oncogenes strong preference Kras2 compared Hras1. Nearly all lacking regressed deinduction, whereas bearing did not, suggesting contribute progression. These findings demonstrate c-MYC-induced pathway involving Kras2.

参考文章(24)
Brammar Wj, Walker Ra, Varley Jm, Whittaker Jl, Swallow Je, Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. ,vol. 1, pp. 423- 430 ,(1987)
Robert Cardiff, P. Leder, W. Muller, E. Sinn, Transgenic oncogene mice. Tumor phenotype predicts genotype. American Journal of Pathology. ,vol. 139, pp. 495- 501 ,(1991)
Lynda Chin, Alice Tam, Jason Pomerantz, Michelle Wong, Jocelyn Holash, Nabeel Bardeesy, Qiong Shen, Ronan O'Hagan, Joe Pantginis, Hao Zhou, James W. Horner, Carlos Cordon-Cardo, George D. Yancopoulos, Ronald A. DePinho#, Essential role for oncogenic Ras in tumour maintenance Nature. ,vol. 400, pp. 468- 472 ,(1999) , 10.1038/22788
A Peña, C D Reddy, S Wu, N J Hickok, E P Reddy, G Yumet, D R Soprano, K J Soprano, Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. Journal of Biological Chemistry. ,vol. 268, pp. 27277- 27285 ,(1993) , 10.1016/S0021-9258(19)74246-X
Claudia S. Huettner, Pu Zhang, Richard A. Van Etten, Daniel G. Tenen, Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nature Genetics. ,vol. 24, pp. 57- 60 ,(2000) , 10.1038/71691
Eric Sinn, William Muller, Paul Pattengale, Isidore Tepler, Racheal Wallace, Philip Leder, Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo Cell. ,vol. 49, pp. 465- 475 ,(1987) , 10.1016/0092-8674(87)90449-1
Stella Pelengaris, Trevor Littlewood, Michael Khan, George Elia, Gerard Evan, Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Molecular Cell. ,vol. 3, pp. 565- 577 ,(1999) , 10.1016/S1097-2765(00)80350-0
C. Bello-Fernandez, G. Packham, J. L. Cleveland, The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 7804- 7808 ,(1993) , 10.1073/PNAS.90.16.7804
Aya Leder, Paul K. Pattengale, Ann Kuo, Timothy A. Stewart, Philip Leder, Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development Cell. ,vol. 45, pp. 485- 495 ,(1986) , 10.1016/0092-8674(86)90280-1
Sandra T. Marquis, Jayant V. Rajan, Anthony Wynshaw-Boris, Junzhe Xu, Gui-Ying Yin, Kenneth J. Abel, Barbara L. Weber, Lewis A. Chodosh, The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues Nature Genetics. ,vol. 11, pp. 17- 26 ,(1995) , 10.1038/NG0995-17